The discussions include references to the small effect size (r=.16) and methodological concerns like underpowered studies and artifact issues, showing critical engagement. Phrases like 'weak association' and mentions of 'small but real consequences' demonstrate nuanced perspectives that acknowledge limitations while still recognizing some relevance for future research.
AgreementNeither agree nor disagree
Most discussions acknowledge the small effect size and methodological limitations, reflecting neutral agreement overall.
InterestModerate interest
There's moderate curiosity shown, especially around new targeting methods and different viewpoints on the study's significance.
EngagementModerate engagement
Participants reference specific aspects like the study’s methodology and findings, indicating a moderate level of deep engagement.
ImpactNeutral impact
The discussions suggest limited impact on clinical practices due to acknowledged weaknesses, but some interest in ongoing research.
Abstract in brief
The study looked at how the brain's functional connectivity, specifically between the subgenual anterior cingulate cortex (sgACC) and the stimulation site, relates to the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in treating depression, but found only a weak association.
Researchers validated that their methods for estimating sgACC connectivity are reliable, and they used electric field modeling to identify stimulation sites, revealing that treatment response is influenced by factors like respiration-related brain signal patterns.
Overall, the findings suggest that individual differences in sgACC connectivity explain only a small part of treatment outcomes, indicating limitations in using this connectivity as a standalone target for personalized depression treatment, although there is some evidence of a true, but small, effect.]
1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE-D); work together with @cl9681, Conor Liston, and the THREE-D team. Below a (belated) summary of our findings:
https://t.co/WNgfsCpn7m
Mar 20, 2023 · 47 likes · 19 shares · 217 followersView post →
NL
NINET Lab
@NinetLab · X
Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 25 likes · 12 shares · 1,270 followersView post →
IE
Immanuel Elbau
@immanuel_elbau · X
8/8 Check out also the commentary by @shansiddiqi & @NoahSPhilipMD (https://t.co/RxmYCuwOWD), and video commentary by Danny Pine (https://t.co/JMGAZlGcpV)
The parent piece, is found here. In brief, the sgACC/DLPC connectivity relationship appeared driven by large signal fluctuations that looked like respiratory artifact to the authors. And, contributing unfortunately little to clinical outcomes.
https://t.co/thqYgEJJVW
Mar 1, 2023 · 3 likes · 1,979 followersView post →
JA
Journals of The American Psychiatric Association
@APAPubJournals · X
Functional Connectivity Mapping for rTMS Target Selection in Depression
https://t.co/P6HjGLVcUc
American Journal of Psychiatry Deputy Editor Daniel S Pine MD discusses recent research on using functional connectivity mapping for rTMS target selection in depression, and the limited impact of sgACC connectivity on…
American Journal of Psychiatry Deputy Editor Daniel S Pine MD discusses the article Functional Connectivity Mapping for rTMS Target Selection in Depression by Immanuel G Elbau MD PhD and colleagues. The study evaluates…
@ColinHawco @josephdviviano @AVoineskos @SOBP and the paper i mentioned above "Functional Connectivity Mapping for rTMS Target Selection in Depression" reports r=.16. Which is pretty much useless. For that effect size it was underpowered. It was also non preregistered. There must be better biomarker studies!
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 23, 2023 · 19 shares · 174 followersView post →
WP
Weill Cornell Medicine Psychiatry
@WCMPsychiatry · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 22, 2023 · 19 shares · 1,293 followersView post →
MF
Michael Fox
@foxmdphd · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 21, 2023 · 19 shares · 6,685 followersView post →
PB
P Petrov (She/Jew/Black)
@dr_ppetrov · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 21, 2023 · 19 shares · 421 followersView post →
MB
Max-Planck EU-Office Bavaria
@EU_MPQ · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 21, 2023 · 19 shares · 596 followersView post →
DY
Debbie Yee
@debyeeneuro · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 21, 2023 · 19 shares · 1,176 followersView post →
あ
あるく
@ayumu_tomaru · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 297 followersView post →
TY
Thomas Yeo
@bttyeo · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 11,814 followersView post →
JS
Joe Stujenske
@jmstujenske · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 271 followersView post →
FG
Faith G
@GunningFaith · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 407 followersView post →
NM
Noah S Philip MD
@NoahSPhilipMD · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 1,979 followersView post →
HK
Helmet Karim
@KarimH349 · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 414 followersView post →
ML
Maximilian Lueckel
@mlueckel · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 398 followersView post →
KS
Klaus Schellhorn
@neuroconn · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 1,216 followersView post →
TB
Til Ole Bergmann
@tobergmann · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 3,674 followersView post →
SS
Shan Siddiqi @shansiddiqi.bsky.social
@shansiddiqi · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 3,680 followersView post →
YA
Yoni Ashar
@YoniAshar · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 1,660 followersView post →
CL
Chuck Lynch
@cl9681 · X
RT @immanuel_elbau: 1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE…
Mar 20, 2023 · 19 shares · 713 followersView post →
IE
Immanuel Elbau
@immanuel_elbau · X
8/8 Check out also the commentary by @shansiddiqi & @NoahSPhilipMD (https://t.co/RxmYCuwOWD), and video commentary by Danny Pine (https://t.co/JMGAZlGcpV)
1/8 Excited to share our new paper at AJP exploring sgACC-based targeting for TMS outcomes in a large MDD sample (THREE-D); work together with @cl9681, Conor Liston, and the THREE-D team. Below a (belated) summary of our findings:
https://t.co/WNgfsCpn7m
Mar 20, 2023 · 47 likes · 19 shares · 217 followersView post →
JA
Journals of The American Psychiatric Association
@APAPubJournals · X
3. Functional Connectivity Mapping for rTMS Target Selection in Depression 3/4
https://t.co/P6HjGLVcUc
RT @APAPubJournals: Choosing brain stimulation targets based on cingulate cortex functional connectivity has small but real consequences fo…
Mar 8, 2023 · 1 share · 1,465 followersView post →
JA
Journals of The American Psychiatric Association
@APAPubJournals · X
Choosing brain stimulation targets based on cingulate cortex functional connectivity has small but real consequences for #depression treatment. https://t.co/wylGY6XZMH https://t.co/TmceAAUcLf
Mar 8, 2023 · 1 like · 1 share · 11,606 followersView post →
BF
Breathe In Courage, Breathe Out Fear
@ZenForceVets · X
Functional Connectivity Mapping for rTMS Target Selection in ... - Am J Psychiatry https://t.co/9oFY04LHUS
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 2, 2023 · 12 shares · 1,216 followersView post →
JS
Jasmina is a PhD student
@jsmnpnv · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 2, 2023 · 12 shares · 587 followersView post →
M李
Meiling Li-李美玲
@xiaoxiaoliu44 · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 2, 2023 · 12 shares · 205 followersView post →
DO
Desmond Oathes
@DesmondOathes · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 2,059 followersView post →
RL
Raymond Lam
@DrRaymondLam · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 2,122 followersView post →
ML
Maximilian Lueckel
@mlueckel · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 398 followersView post →
PT
Parsa Tadayon
@parsa_tad · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 131 followersView post →
IE
Immanuel Elbau
@immanuel_elbau · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 217 followersView post →
TB
Til Ole Bergmann
@tobergmann · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 3,674 followersView post →
N
Neurosys
@systems_neuro · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 405 followersView post →
NM
Noah S Philip MD
@NoahSPhilipMD · X
RT @NinetLab: Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 12 shares · 1,979 followersView post →
NL
NINET Lab
@NinetLab · X
Check out the latest from the THREE-D trial "FC Mapping for rTMS Target Selection in Depression" https://t.co/44V4xe4ORS
Mar 1, 2023 · 25 likes · 12 shares · 1,270 followersView post →
NM
Noah S Philip MD
@NoahSPhilipMD · X
The parent piece, is found here. In brief, the sgACC/DLPC connectivity relationship appeared driven by large signal fluctuations that looked like respiratory artifact to the authors. And, contributing unfortunately little to clinical outcomes.
https://t.co/thqYgEJJVW
Mar 1, 2023 · 3 likes · 1,979 followersView post →
BF
Breathe In Courage, Breathe Out Fear
@ZenForceVets · X
Functional Connectivity Mapping for rTMS Target Selection in ... - Am J Psychiatry https://t.co/9oFY04LHUS
Functional Connectivity Mapping for rTMS Target Selection in ...
News
... 10.1176/appi.ajp.20220306. Repetitive transcranial magnetic stimulation (rTMS) to the Precise effect size estimates are specifically important for left ...